These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2190784)

  • 1. Diurnal variation in glucose and leucine metabolism in non-insulin-dependent diabetes.
    Umpleby AM; Scobie IN; Boroujerdi MA; Carson ER; Sonksen PH
    Diabetes Res Clin Pract; 1990 Apr; 9(1):89-96. PubMed ID: 2190784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes.
    Shapiro ET; Polonsky KS; Copinschi G; Bosson D; Tillil H; Blackman J; Lewis G; Van Cauter E
    J Clin Endocrinol Metab; 1991 Feb; 72(2):444-54. PubMed ID: 1991813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM.
    Luzi L; Petrides AS; De Fronzo RA
    Diabetes; 1993 Dec; 42(12):1868-77. PubMed ID: 8243833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of recombinant human insulin-like growth factor I and insulin on counterregulation during acute plasma glucose decrements in normal and type 2 (non-insulin-dependent) diabetic subjects.
    Laager R; Keller U
    Diabetologia; 1993 Oct; 36(10):966-71. PubMed ID: 8243878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bedtime insulin for suppression of overnight free-fatty acid, blood glucose, and glucose production in NIDDM.
    Taskinen MR; Sane T; Helve E; Karonen SL; Nikkilä EA; Yki-Järvinen H
    Diabetes; 1989 May; 38(5):580-8. PubMed ID: 2653929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
    Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
    Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of metabolic control on leucine metabolism in type 1 (insulin-dependent) diabetic patients.
    Umpleby AM; Boroujerdi MA; Brown PM; Carson ER; Sönksen PH
    Diabetologia; 1986 Mar; 29(3):131-41. PubMed ID: 3699304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production.
    Boden G; Chen X; Urbain JL
    Diabetes; 1996 Aug; 45(8):1044-50. PubMed ID: 8690150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of superphysiologic hyperinsulinemia on glucose and lipid metabolism in glucose-tolerant offspring of patients with non-insulin-dependent diabetes mellitus (NIDDM).
    Osei K
    Diabetes Res Clin Pract; 1992 Sep; 17(3):169-82. PubMed ID: 1425156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RU 486 prevents the acute effects of cortisol on glucose and leucine metabolism.
    Garrel DR; Moussali R; De Oliveira A; Lesiège D; Larivière F
    J Clin Endocrinol Metab; 1995 Feb; 80(2):379-85. PubMed ID: 7888013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin.
    Ubukata E
    Ann Nutr Metab; 1990; 34(6):333-42. PubMed ID: 2076025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM.
    Saloranta C; Taskinen MR; Widen E; Härkönen M; Melander A; Groop L
    Diabetes; 1993 Nov; 42(11):1559-66. PubMed ID: 8405695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective suppression by insulin of leucine-carbon appearance and oxidation in type 1, insulin-dependent diabetes mellitus. Evidence for insulin resistance involving glucose and amino acid metabolism.
    Tessari P; Nosadini R; Trevisan R; De Kreutzenberg SV; Inchiostro S; Duner E; Biolo G; Marescotti MC; Tiengo A; Crepaldi G
    J Clin Invest; 1986 Jun; 77(6):1797-804. PubMed ID: 3519679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis.
    Nielsen MF; Wise S; Dinneen SF; Schwenk WF; Basu A; Rizza RA
    Diabetes; 1997 Dec; 46(12):2007-16. PubMed ID: 9392488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol.
    Basu A; Caumo A; Bettini F; Gelisio A; Alzaid A; Cobelli C; Rizza RA
    Diabetes; 1997 Mar; 46(3):421-32. PubMed ID: 9032098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of acute daytime and nocturnal insulinization on diurnal glucose homeostasis in NIDDM.
    Puhakainen I; Taskinen MR; Yki-Järvinen H
    Diabetes Care; 1994 Aug; 17(8):805-9. PubMed ID: 7956622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
    Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipolysis and gluconeogenesis from glycerol are increased in patients with noninsulin-dependent diabetes mellitus.
    Puhakainen I; Koivisto VA; Yki-Järvinen H
    J Clin Endocrinol Metab; 1992 Sep; 75(3):789-94. PubMed ID: 1517368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal variation in insulin sensitivity of glucose metabolism is associated with diurnal variations in whole-body and cellular fatty acid metabolism in metabolically normal women.
    Yoshino J; Almeda-Valdes P; Patterson BW; Okunade AL; Imai S; Mittendorfer B; Klein S
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1666-70. PubMed ID: 24878055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoflurane and whole body leucine, glucose, and fatty acid metabolism in dogs.
    Horber FF; Krayer S; Miles J; Cryer P; Rehder K; Haymond MW
    Anesthesiology; 1990 Jul; 73(1):82-92. PubMed ID: 2360744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.